High expression of EZH2 is associated with tumor proliferation and prognosis in human oral squamous cell carcinomas
Authors:
- Kazunori KidaniKKKazunori Kidani
- Mitsuhiko OsakiMOMitsuhiko Osaki
- Takayuki TamuraTTTakayuki Tamura
- Kensaku YamagaKYKensaku Yamaga
- Kohei ShomoriKSKohei Shomori
- Kazuo RyokeKRKazuo Ryoke
- Hisao ItoHIHisao Ito
- 1 January 2009
- journal article
- Published by Elsevier in Oral Oncology
- Vol. 45 (1) , 39-46
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Correlation of proliferative markers (Ki-67 and PCNA) with survival and lymph node metastasis in oral squamous cell carcinoma: a clinical and histopathological analysis of 113 patientsInternational Journal of Oral and Maxillofacial Surgery, 2006
- Expression of the enhancer of zeste homolog 2 is correlated with poor prognosis in human gastric cancerCancer Science, 2006
- Identification of EZH2 as a Molecular Marker for a Precancerous State in Morphologically Normal Breast TissuesCancer Research, 2006
- Increased Expression of EZH2, a Polycomb Group Protein, in Bladder CarcinomaUrologia Internationalis, 2005
- Cyclo-oxygenase-1 and -2 expression in human oral mucosa, dysplasias and squamous cell carcinomas and their pathological significanceOral Oncology, 2005
- Transcription factor E2F3 overexpressed in prostate cancer independently predicts clinical outcomeOncogene, 2004
- The Expanding Role of Systemic Therapy in Head and Neck CancerJournal of Clinical Oncology, 2004
- Role of Histone H3 Lysine 27 Methylation in Polycomb-Group SilencingScience, 2002
- The polycomb group protein EZH2 is involved in progression of prostate cancerNature, 2002
- The p53 tumor‐suppressor gene and ras oncogene mutations in oral squamous‐cell carcinomaInternational Journal of Cancer, 1992